We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
+17.12%
1 Year Est. Return
+35.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$72M
AUM Growth
-$2.02M
Cap. Flow
-$13.2M
Cap. Flow %
-18.39%
Top 10 Hldgs %
55.78%
Holding
74
New
10
Increased
7
Reduced
41
Closed
11

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$1.84M
2
FDX icon
FedEx
FDX
+$1.27M
3
CLDR
Cloudera, Inc.
CLDR
+$1.24M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.24M
5
PVTL
Pivotal Software, Inc.
PVTL
+$1.18M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$4.46M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$4.36M
3
GM icon
General Motors
GM
+$1.83M
4
VTWO icon
Vanguard Russell 2000 ETF
VTWO
+$1.25M
5
BIIB icon
Biogen
BIIB
+$857K

Sector Composition

Rank Sector Weight
1 Healthcare 17.15%
2 Financials 15.01%
3 Communication Services 14.08%
4 Technology 12.22%
5 Consumer Discretionary 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ET icon
51
Energy Transfer Partners
ET
$69.3B
$168K 0.23%
+10,954
New +$163K
AM icon
52
Antero Midstream
AM
$10.1B
$152K 0.21%
+11,004
New +$144K
EIGI
53
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$145K 0.2%
20,001
-21,586
-52% -$157K
SPPI
54
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$140K 0.19%
13,054
-4,500
-26% -$48.2K
RESI
55
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$138K 0.19%
14,837
-69,650
-82% -$727K
DO
56
DELISTED
Diamond Offshore Drilling
DO
$132K 0.18%
12,538
-429
-3% -$4.53K
IOVA icon
57
Iovance Biotherapeutics
IOVA
$2.87B
$97K 0.13%
10,155
-3,500
-26% -$34K
KPTI icon
58
Karyopharm Therapeutics
KPTI
$48M
$85K 0.12%
969
-800
-45% -$88.7K
RIGL icon
59
Rigel Pharmaceuticals
RIGL
$750M
$37K 0.05%
+1,444
New +$33K
EQS icon
60
Equus Total Return
EQS
$16.8M
$33K 0.05%
17,286
– –
MTL.PR
61
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$27K 0.04%
38,123
– –
KA
62
DELISTED
Kineta, Inc. Common Stock
KA
$18K 0.03%
+103
New +$50.4K
GMO
63
DELISTED
General Moly, Inc.
GMO
$4K 0.01%
17,982
– –
ABT icon
64
Abbott
ABT
$187B
– –
-9,158
Closed -$662K
FOLD
65
DELISTED
Amicus Therapeutics
FOLD
– –
-18,053
Closed -$173K
INCY icon
66
Incyte
INCY
$24.4B
– –
-5,464
Closed -$347K
MRK icon
67
Merck
MRK
$318B
– –
-5,108
Closed -$372K
VKTX icon
68
Viking Therapeutics
VKTX
$4B
– –
-11,703
Closed -$90K
ICPT
69
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-3,901
Closed -$393K
ZYNE
70
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-11,703
Closed -$35K
AERI
71
DELISTED
Aerie Pharmaceuticals
AERI
– –
-9,021
Closed -$326K
GBT
72
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-5,071
Closed -$208K
ARRY
73
DELISTED
Array Biopharma Inc
ARRY
– –
-15,564
Closed -$222K
TSRO
74
DELISTED
TESARO, Inc.
TSRO
– –
-4,234
Closed -$314K
1 2
3

Similar funds

MRP
Measured Risk Portfolios San Diego, California $91.4M AUM 0.88% 1-Year Est. Return
ITG
Index Technologies Group New York $91.8M AUM
MA
Marquette Associates Chicago, Illinois $91.9M AUM 13.47% 1-Year Est. Return
AW
Aspirean Wealth Mill Valley, California $92.1M AUM
SPCM
Spruce Point Capital Management New York $90.9M AUM
ML
MLP3 LLC Linwood, New Jersey $90.7M AUM
ICM
Incision Capital Management San Francisco, California $90.6M AUM
ACMC
Anchor Capital Management Company Raleigh, North Carolina $92.7M AUM 19.36% 1-Year Est. Return

Kazazian Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Kazazian Asset Management held 74 positions worth $72M, down 2.7% from $74M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Kazazian Asset Management withdrew a net $13.2M in Q1 2019, closing 11 positions and reducing 41 holdings. Its most notable exit was Abbott, an estimated $662K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 21% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Kazazian Asset Management opened a new position in Cloudera, Inc. worth $1.06M.

  • Kazazian Asset Management's largest Q1 2019 buy was Cloudera, Inc.: 96,748 shares worth $1.06M.
  • Kazazian Asset Management added most to Baidu in Q1 2019, an estimated $1.84M increase.
  • Kazazian Asset Management's biggest Q1 2019 reduction was Goldman Sachs, cutting an estimated $4.46M.
  • Kazazian Asset Management fully exited Abbott in Q1 2019, selling an estimated $662K.
  • Kazazian Asset Management's ten largest holdings make up 56% of its $72M portfolio in Q1 2019.
  • Kazazian Asset Management opened 10 new positions and closed 11 in Q1 2019.
  • Kazazian Asset Management's portfolio value fell 2.7% quarter-over-quarter to $72M.

Based on Kazazian Asset Management's 13F filing for Q1 2019, filed 15 May 2019.